Silencing phospholipid scramblase 1 expression by RNA interference in colorectal cancer and metastatic liver cancer

Hepatobiliary and Pancreatic Diseases International

Volumn 11, Issue 4, 2012, Pages 393-400

  Cui, Wei ^a   Li, Shi Yong ^a   Du, Jun Feng ^a   Zhu, Zi Man ^a   An, Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Colorectal cancer; Metastatic liver cancer; Phospholipid scramblase 1; RNA interference

Indexed keywords

FIBRONECTIN; LAMININ; OLIGONUCLEOTIDE; SCRAMBLASE; TETRAZOLIUM;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE THERAPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROTEIN EXPRESSION; RNA INTERFERENCE;

EID: 84865123548     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1499-3872(12)60197-0     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Wilke HJ, Van Cutsem E. Current treatments and future perspectives in colorectal and gastric cancer. Ann Oncol 2003;14:ii49-55.
3. Baca B, Beart RW Jr, Etzioni DA. Surveillance after colorectal cancer resection: a systematic review. Dis Colon Rectum 2011;54:1036-1048.
4. Matsubara N. Epigenetic regulation and colorectal cancer. Dis Colon Rectum 2012;55:96-104.
5. Sims PJ, Wiedmer T. Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 2001;86:266-275.
6. Sahu SK, Gummadi SN, Manoj N, Aradhyam GK. Phospholipid scramblases: an overview. Arch Biochem Biophys 2007;462:103-114.
7. Huang Y, Zhao Q, Chen GQ. Phospholipid scramblase 1. Sheng Li Xue Bao 2006;58:501-510.
8. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
9. Martinez J, Patkaniowska A, Urlaub H, Lührmann R, Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002;110:563-574.
10. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nat Rev Genet 2002;3:737-747.
11. Shi Y. Mammalian RNAi for the masses. Trends Genet 2003;19:9-12.
12. Grimm D, Kay MA. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time? J Clin Invest 2007;117:3633-3641.
13. Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007;59:75-86.
14. Zhao F, Zhang Q, Kang C, Cui X, Wang T, Xu P, et al. Suppression of matrix metalloproteinase-9 expression by RNA interference inhibits SGC7901 gastric adenocarcinoma cell growth and invasion in vitro and in vivo. Med Oncol 2010;27:774-784.
15. Kuo YB, Chan CC, Chang CA, Fan CW, Hung RP, Hung YS, et al. Identification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancer. Mol Med 2011;17:41-47.
16. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
17. Lu B, Sims PJ, Wiedmer T, Moser AH, Shigenaga JK, Grunfeld C, et al. Expression of the phospholipid scramblase (PLSCR) gene family during the acute phase response. Biochim Biophys Acta 2007;1771:1177-1185.
18. Nakamaki T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Hino K, Tomoyasu S, Honma Y, et al. Role of MmTRA1b/ phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes. Exp Hematol 2002;30:421-429.
19. Silverman RH, Halloum A, Zhou A, Dong B, Al-Zoghaibi F, Kushner D, et al. Suppression of ovarian carcinoma cell growth in vivo by the interferon-inducible plasma membrane protein, phospholipid scramblase 1. Cancer Res 2002;62:397-402.
20. Vinayagam A, Stelzl U, Foulle R, Plassmann S, Zenkner M, Timm J, et al. A directed protein interaction network for investigating intracellular signal transduction. Sci Signal 2011;4:rs8.
21. Nanjundan M, Sun J, Zhao J, Zhou Q, Sims PJ, Wiedmer T. Plasma membrane phospholipid scramblase 1 promotes EGFdependent activation of c-Src through the epidermal growth factor receptor. J Biol Chem 2003;278:37413-37418.
22. Yokoyama A, Yamashita T, Shiozawa E, Nagasawa A, Okabe- Kado J, Nakamaki T, et al. MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia. Leuk Res 2004;28:149-157.
23. Dong B, Zhou Q, Zhao J, Zhou A, Harty RN, Bose S, et al. Phospholipid scramblase 1 potentiates the antiviral activity of interferon. J Virol 2004;78:8983-8993.